Advanced Antimicrobial Additive for Next-Gen Polymers
MicroDome®
Innovate Safely.
Build Smarter.
Protect Always.
At the forefront of material science innovation, MicroDome is our proprietary antimicrobial additive technology engineered to integrate effortlessly into a wide range of polymer resin matrices. From PLA and nylon to polypropylene and other thermoplastics, MicroDome enables manufacturers to transform everyday materials into value-added, antimicrobial-enhanced products without disrupting existing production processes.
Developed for both traditional polymer processing and additive manufacturing ( such as 3D printing ), MicroDome offers unmatched versatility and performance across industries such as healthcare, aerospace and defense and more.
Why
MicroDome®
Stands Out
Unmatched Antimicrobial Efficacy
In comparative studies, MicroDome-infused PLA significantly outperforms competitors in antimicrobial performance—delivering faster kill rates, prolonged protection, and superior surface protection.
Seamless Resin Integration
Designed for broad compatibility across polymer systems, MicroDome blends easily into existing manufacturing workflows without reformulation or retooling.
Molecular-Level Engineering
Built on advanced material science, MicroDome ensures uniform dispersion, long-lasting durability, and consistent antimicrobial activity across product lifecycles.
Regulatory Confidence*
Compliant with PMRA’s Treated Articles criteria—helping you bring innovative, antimicrobial-enhanced products to market with confidence and speed.
Scalable & Efficient
Whether you’re scaling small-batch pilot runs or full industrial production, MicroDome is designed to adapt—making integration as seamless as its results.
*TREATED ARTICLE CLASSIFICATION
For Example MicroDome infused 3D Filament is designated a “treated article,” meaning its antimicrobial effect targets microbial growth on the printed object’s surface. It is not intended to mitigate human exposure to pathogens or function as a medical device.
The potential exists for printed end-use objects from these filaments can be registered with a formal regulatory process PMRA in Canada or EPA in the United States to have health claims for the medical device level I. These objects or classes of objects would carry a health claim post-regulatory approval.